Products for Research Use Only
RegisterLogin

Pinatuzumab vedotin

CAT: 0957-D4017-01Size: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0957-D4017-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Pinatuzumab Vedotin (RG-7593, DCDT2980S, DCDT-2989S), is an antibody-drug conjugate (ADC) composed of CD22 (Sialic acid binding Ig-like lectin 2, SIGLEC2, SIGLEC-2, B-lymphocyte cell adhesion molecule, BL-CAM, Leu-14) antibody and cytotoxic agent monomethyl auristatin E (MMAE) conjugated through maleimidocaproyl-valyl-citrullinyl-p-aminobenzyloxycarbonyl (mc-val-cit-PABC) type linker.
CAS Number
1791416-49-3
Synonyms
RG-7593, DCDT2980S, DCDT-2989S
Target
CD markers
Activity
Transmembrane Transporters
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Related Products

CatalogName
D4045-01Brentuximab vedotin
D4013-01Zilovertamab vedotin
D4051-1mgTisotumab vedotin
D4045-1mgBrentuximab vedotin
D4038-1mg*5Enapotamab vedotin
D4019-1mgSirtratumab vedotin
D4009-1mgIndusatumab vedotin
D4046-01Telisotuzumab vedotin
D4019-01Sirtratumab vedotin
D4057-1mgLadiratuzumab vedotin

Alternative Products

CatalogName
HY-141602-01Pinatuzumab vedotin
MBS1581193-01Pinatuzumab vedotin (ADC)
GTR18401359-01Pinatuzumab vedotin Antibody
592115Pinatuzumab Vedotin (CD22)
KBI1556KRIBIOLISA™ Pinatuzumab Vedotin ELISA
ICH5093V-0.1mgPinatuzumab Vedotin Biosimilar - Research Grade
10-588Pinatuzumab Vedotin (CD22) - Research Grade Biosimilar
F1129-50Anti-Siglec-2/CD22 Antibody (Pinatuzumab vedotin)
GTR18117326Pinatuzumab Vedotin (CD22) - Research Grade Biosimilar Antibody
BIO0877SM-1mgAnti-human Siglec-2 / CD22 (Pinatuzumab vedotin Biosimilar)

Popular Products